Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Economic Experts on Managed Care

Articles with lock require a subscription to GLG News | Request a free trial
November 13, 2008
Tamper Proof Narcotic Pain pill? YES
Analysis of: FDA Asks if Pain Pill Is Tamper-Proof | online.wsj.com
Author: David Zimmerman, President/Owner, Doctors of Pharmacy, Inc.
This drug will allow patients in severe pain to get the necessary pain relief and not have to worry about the other patients that abuse the drug.
November 12, 2008
Science vs Marketing
Analysis of: Pharma need not worry too much about President Obama | www.pharmatimes.com
Author: GLG Expert Contributor
The Obama vision is based on science driving the prescription process.  As such, DTC advertising and the sampling of brand name medications will either be restricted or incentives provided to MDs to replace samples with vouchers.  PBMs will be required to be absolutely transparent and Medicare...
November 12, 2008
Many Key Healthcare Players Will See Drop
Analysis of: Hospitals See Drop in Paying Patients | www.nytimes.com
Author: GLG Expert Contributor
Not just hospitals, but many players will see receivables drop including wellness and disease management companies, imaging diagnostics and labs, and soon manufacturers.
Ken PowellNovember 10, 2008
Molecular Markers for Prostate Cancer
Analysis of: Health Discovery Corporation: Four Genes Comprising the New Molecular Diagnostic Signature for Prostate Cancer Successfully Identified in Urine | www.marketwatch.com
Author: Ken Powell, President, Genesis Business Development
New molecular markers for prostate cancer identified by Health Discovery Corporation (OTC BB: HDVY.OB) could prove to me more specific and sensitive than conventional serum assays for prostrate cancer.  In addition, since this urine-based test is non-invasive, it could increase compliance...
Ken PowellNovember 6, 2008
FDA Regulation of Molecular diagnostics
Analysis of: Sales of Test for Ovarian Cancer Halted | www.nytimes.com
Author: Ken Powell, President, Genesis Business Development
The FDA's recent warning letter to Labcorp regarding the sale of OvaSure, a molecular diagnostic test for ovarian cancer, demonstrates the FDA's intent to step up their oversight of molecular diagnostic tests.  Diagnostic companies involved in developing novel molecular diagnostic tests...
Ken PowellNovember 6, 2008
New MRSA Test
Analysis of: ReaX™ PCR Assays For Effortless Detection of Hospital Acquired Infections | www.medcompare.com
Author: Ken Powell, President, Genesis Business Development
The high cost of Hospital Acquired Infections (HAIs) is drawing new competitors into this fast growing In Vitro Diagnostics (IVD) market segment.  New entrants such as Q Chip Ltd and others will accelerate market awareness of HAIs, solutions and enable global market...
Ken PowellNovember 6, 2008
HIV Point-of-Care Screening Shows Benefits
Analysis of: Rapid HIV Testing in the ER Boosts Diagnoses, Screening | www.medcompare.com
Author: Ken Powell, President, Genesis Business Development
A recent study by researchers at Henry Ford Hospital in Michigan showed that screening of patients in the Emergency Department (ED) found that 1 on 50 patients tested for sexually transmitted diseases were infected with HIV.  Screening programs such as these and CDC recommendations to screen...
October 28, 2008
seroquel xl a new formulation
Analysis of: AstraZeneca's Seroquel XL, Once Daily Formula, Now Available For UK Patients | www.medicalnewstoday.com
Author: GLG Expert Contributor
Seroquel is an atypical antipsychotic that has efficacy in 2 very serious mental illnesses- schizophrenia and bipolar disorder. A symptom of both illnesses can be cognitive impairment , confusion, and non-compliance. A once a day formulation of any of their meds helps with compliance and thus maximizes...
October 23, 2008
Indian Economy strengthening: Mobile users in India - an indicative of Economy
Analysis of: Slowdown? India adds 10 mn mobile users in Sept | www.business-standard.com
Author: GLG Expert Contributor
Indian economy is not slowing down even if global finacial market is in crises.  The indian population has been denied the access of the convenient and comfort of the land-line telephone facilities due to unaffordable high price to use them.  Now the introduction of mobile phone gives them...
October 16, 2008
Does this dosage form really add anything?
Analysis of: Watson Announces Positive Data for Its Investigational Oxybutynin Topical Gel for the Treatment of Overactive Bladder at SUNA's Annual Conference | www.pipelinereview.com
Author: GLG Expert Contributor
The comparator product to oxybutynin topical gel (OTG) is Ditropan XL which is also a once daily drug.

Previous Page : 1 2 3 4 5 6 7 8 9 10 11 Next11 to 20 of 527

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-12-02T13:45:17.613